UCP2 and atherosclerosis: Furthermore, we demonstrated that vulnerable psEVs promoted endothelial inflammation and atherosclerosis, partially through the delivery of miR‐497‐5p and subsequent suppression of UCP2, thereby activating the ROS/TXNIP/NLRP3 pathway, a well‐established mechanism of NLRP3 activation [57].